When was LPixel founded?

LPixel was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is LPixel located?

LPixel is headquartered in Tokyo, Japan.

How many employees does LPixel have?

As of May 31, 2026, the latest employee count at LPixel is 41.

Is LPixel a funded company?

LPixel is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Oct 24, 2016.

When was the latest funding round of LPixel?

LPixel's latest funding was a $***** Series A round on Oct 24, 2016, with participation from 1 investor.

Where does LPixel rank among its competitors?

LPixel ranks 17th amongst 238 active competitors, of which 61 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of LPixel?

LPixel's top competitors include PathAI, Oxipit and Deciphex. Among them, Techcyte secured the most recent funding round in April, 2026.

LPixel - 2026 Company Profile, Team, Funding & Competitors

LPixel is a series A company based in Tokyo (Japan), founded in 2014 by Yuki Shimahara. It operates as an Image analysis tools using artificial intelligence. LPixel has raised $7M in funding from JAFCO Group. The company has 238 active competitors, including 61 funded and 15 that have exited. Its top competitors include companies like PathAI, Oxipit and Deciphex.

Company Details

LPixel develops image analysis tools using artificial intelligence. It has two products for life sciences. The first product is a suite of general purpose image management tools that prevents misuse of scientific images, 3D measurement kit for plants, and software for motion tracking, and color analyses. It is also developing an AI-based image analysis tool for the detection of cancer.

Website: lpixel.net
Social
Email ID: *****@lpixel.net

Key Metrics

Founded Year

2014

Location

Tokyo, Japan

Stage

Series A

Total Funding

$7M in 1 round

Latest Funding Round

Series A, Oct 24, 2016, $*****

Investors

JAFCO Group & 7 more

Ranked

17^th among 238 active competitors

Employee Count

41 as on May 31, 2026

Similar Companies

PathAI & 278 more

View LPixel's full profile

LPixel has raised a total funding of $7M over 1 round. Its latest funding round was a Series A round on Oct 24, 2016 for $*****. 1 investor participated in its latest round. LPixel has 8 institutional investors.

Here is the list of recent funding rounds of LPixel:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 24, 2016	3681875	Series A	7065133	8330002	2479930	7421744

Access funding benchmarks and valuations. Sign up today!

View details of LPixel's funding rounds and investors

The founders of LPixel is Yuki Shimahara. Kamada Tomy is the CEO of LPixel.

Here are the details of LPixel's key team members:

Yuki Shimahara: Former Founder of LPixel.
Kamada Tomy: CEO of LPixel.

View details of LPixel's Founder profiles and Board Members

LPixel's employee count trend

LPixel has 41 employees as of May 26. Here is LPixel's employee count trend over the years:

Uncover LPixel's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LPixel include PathAI, Oxipit and Deciphex. Here is the list of Top 10 competitors of LPixel, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
2nd	Oxipit 2017, Vilnius (Lithuania), Acquired	Artificial intelligence based medical image analysis	$6.69M	Practica Capital, CoInvest Capital & 4 others	68/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
6th	Lunit 2013, Seoul (South Korea), Public	Developer of artificial intelligence solutions for cancer detection and treatment	$135M	InterVest, Shinhan Investment Corp & 24 others	62/100
7th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
8th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
9th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
10th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
17th	LPixel 2014, Tokyo (Japan), Series A	Image analysis tools using artificial intelligence	$7M	SBI Investment, Mistletoe & 6 others	56/100